Skip to main content

Jefferies Financial Group Inc.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 96223 NEW YORK, NY

Position in TEVA

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$950,707
+$489,361 QoQ
Shares Held
31,564
+113.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Mar 31, 2024
CallValue
$1,183,829
CallShares
83,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Jefferies Financial Group Inc. holds $32,795,534 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TEVA
Teva Pharmaceutical Industries Ltd
This page
31,564 $950,707

All Filings in TEVA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $950,707 31,564
2025-12-31 $461,346 14,782
2024-12-31 $331,657 15,048
2024-06-30 $345,312 21,250
2024-03-31 $1,183,829 83,900
2023-06-30 $380,265 50,500
2023-06-30 $124,448 16,527
2023-06-30 $376,500 50,000
2023-03-31 $885,000 100,000
2023-03-31 $8,885 1,004
2022-12-31 $1,910,402 209,474
2022-12-31 $3,285,024 360,200